中医药防治过敏性鼻炎-哮喘综合征研究述评*

doi:10.3969/j.issn.1006-2157.2021.03.002

北京中医药大学学报 ›› 2021, Vol. 44 ›› Issue (3): 203-208.doi: 10.3969/j.issn.1006-2157.2021.03.002

中医药防治过敏性鼻炎-哮喘综合征研究述评^*

崔红生¹, 吕明圣^1,2, 王济³, 毕伟博¹, 弓雪峰^1,2

1 北京中医药大学第三附属医院北京 100029;
2 北京中医药大学;
3 北京中医药大学国家中医体质与治未病研究院

收稿日期:2020-11-20 出版日期:2021-03-30 发布日期:2021-03-30
作者简介:崔红生,男,博士,教授,主任医师,博士生导师,主要研究方向:中医药防治呼吸系统疾病,E-mail:hshcui@sina.com
基金资助:
*国家自然科学基金面上项目(No.81973715, No.82074390),北京市自然科学基金面上项目(No.7202110)

Evaluation of studies of prevention and treatment of combined allergic rhinitis and asthma syndrome with TCM^*

Cui Hongsheng¹, Lyu Mingsheng^1,2, Wang Ji³, Bi Weibo¹, Gong Xuefeng^1,2

1 Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, China;
2 Beijing University of Chinese Medicine, Beijing 100029, China;
3 National Institute of Traditional Chinese Medicine Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing 100029, China

Received:2020-11-20 Online:2021-03-30 Published:2021-03-30
Contact: Prof. Cui Hongsheng, M.D., Chief Physician, Doctoral Supervisor. Beijing University of Chinese Medicine Third Affiliated Hospital. No. 51 Xiaoguan Street, Chaoyang District, Beijing 100029. E-mail: hshcui@sina.com
Supported by:
National Natural Science Foundation of China (No. 81973715, No. 82074390), Beijing Natural Science Foundation (No. 7202110)

摘要/Abstract

摘要： 过敏性鼻炎-哮喘综合征(CARAS)是典型的变态反应性疾病,也是呼吸系统的常见病及难治症,其患病率高,发病机制复杂,治疗手段有限,且易反复发作。中医药以整体辨证、综合治疗为特色,在此病临床诊治中有重要价值。本文对CARAS的病理机制、病因病机及中医药治疗研究等方面进行了文献述评,认为“特禀质”是CARAS患者的主要体质类型,伏邪干肺是其核心病机,“辨体-辨病-辨证”诊疗模式是其临床防治思路,随机对照试验及大样本真实世界研究是其未来研究方向。

关键词: 过敏性鼻炎-哮喘综合征, 病因病机, 治疗研究, 临床思路

Abstract: The combined allergic rhinitis and asthma syndrome (CARAS) is not only a typical allergic disease but a common and refractory disorder of the respiratory system with high prevalence rate and complex pathogenesis. Due to limited therapies, CARAS is prone to recurrent attacks. Traditional Chinese medicine (TCM), characterized by overall pattern differentiation and systemic therapy, has been proved to be valuable in the treatment of CARAS. Literature on CARAS was reviewed in terms of its etiology, pathogenesis, and treatment with TCM. Based on that, it is concluded that the special-diathesis constitution is the primary constitution of patients with CARAS, that latent pathogen attacks the lung is the core pathogenesis, constitution-disease-pattern differentiation is the way of diagnosis and treatment in clinical prevention and treatment, and the randomized controlled trial and large-sample real-world research would be the directions of future clinical study.

Key words: combined allergic rhinitis and asthma syndrome, etiology and pathogenesis, treatment research, clinical research idea

中图分类号:

R256.1

崔红生, 吕明圣, 王济, 毕伟博, 弓雪峰. 中医药防治过敏性鼻炎-哮喘综合征研究述评^*[J]. 北京中医药大学学报, 2021, 44(3): 203-208.

Cui Hongsheng, Lyu Mingsheng, Wang Ji, Bi Weibo, Gong Xuefeng. Evaluation of studies of prevention and treatment of combined allergic rhinitis and asthma syndrome with TCM^*[J]. JOURNAL OF BEIJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE, 2021, 44(3): 203-208.

参考文献

[1] Paiva Ferreira LKD, Paiva Ferreira LAM, Monteiro TM, et al. Combined allergic rhinitis and asthma syndrome (CARAS)[J]. Int Immunopharmacol, 2019,74:105718.
[2] Broiek JL, Bousquet J, Agache I, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines - 2016 revision[J]. J Allergy Clin Immunol, 2017,140(4):950-958.
[3] Shen Y, Zeng JH, Hong SL, et al. Prevalence of allergic rhinitis comorbidity with asthma and asthma with allergic rhinitis in China: a meta-analysis[J]. Asian Pac J Allergy Immunol, 2019,37(4):220-225.
[4] Hill DA, Spergel JM. The atopic march: critical evidence and clinical relevance[J]. Ann Allergy Asthma Immunol, 2018,120(2):131-137.
[5] Morjaria JB, Caruso M, Emma R, et al. Treatment of allergic rhinitis as a strategy for preventing asthma[J]. Curr Allergy Asthma Rep, 2018,18(4):23.
[6] Davidson WF, Leung DYM, Beck LA, et al. Report from the National Institute of Allergy and Infectious Diseases workshop on “Atopic dermatitis and the atopic march: Mechanisms and interventions”[J]. J Allergy Clin Immunol, 2019,143(3):894-913.
[7] Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study[J]. Lancet, 2019,394(10196):407-418.
[8] Grossman J. One airway, one disease[J]. Chest, 1997,111(2 Suppl):11-16.
[9] Lambrecht BN, Hammad H. The immunology of asthma[J]. Nat Immunol, 2015,16(1):45-56.
[10] Yu Y, Blokhuis BR, Garssen J, et al. Non-IgE mediated mast cell activation[J]. Eur J Pharmacol, 2016,778:33-43.
[11] 王成鑫.中医药治疗过敏性鼻炎-哮喘综合征文献研究及崔红生教授经验总结[D].北京:北京中医药大学,2019.
Wang CX. Literature study on the combined allergic rhinitis and asthma syndrome treated with traditional Chinese medicine and the summary of experience drawn from Professor Cui Hongsheng in treating the combined allergic rhinitis and asthma syndrome[D]. Beijing: Beijing University of Chinese Medicine, 2019.
[12] 史锁芳,王德钧,杨继兵,等.益气祛风、宣痹化饮方治疗过敏性鼻炎哮喘综合征的临床观察[J].中国中医急症,2016,25(5):921-924.
Shi SF, Wang DJ, Yang JB, et al. Curative effect observation of Yiqi Qufeng Xuanbi Huayin Decoction on combined allergic rhinitis and asthma syndrome (CARAS)[J]. Journal of Emergency in Traditional Chinese Medicine, 2016,25(5):921-924.
[13] 景伟超,刘璐佳,关洋洋,等.王有鹏基于分消走泄法治疗过敏性鼻炎-哮喘综合征经验[J].辽宁中医杂志,2019,46(3):483-485.
Jing WC, Liu LJ, Guan YY, et al. Wang Youpeng's experience on treating allergic rhinitis and asthma syndrome based on purging and eliminating method[J]. Liaoning Journal of Traditional Chinese Medicine, 2019,46(3):483-485.
[14] 毕伟博,姜旻,崔红生,等.从奇经论治过敏性鼻炎-哮喘综合征[J].中华中医药杂志,2018,33(5):1781-1784.
Bi WB, Jiang M, Cui HS, et al. Treatment of combined allergic rhinitis and asthma syndrome by means of extra-meridians[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2018,33(5):1781-1784.
[15] 李玲孺,张惠敏,王济,等.王琦辨体-辨病-辨证治疗过敏性疾病经验[J].中医杂志,2012,53(20):1720-1723.
Li LR, Zhang HM, Wang J, et al. Wang Qi's experience on treating allergic diseases by the pattern of Constitution-Disease-Syndrome Differentiation[J]. Journal of Traditional Chinese Medicine, 2012,53(20):1720-1723.
[16] 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(2020年版)[J].中华结核和呼吸杂志,2020,43(12):1023-1048.
Asthma Group, Chinese Throacic Society, Chinese Medical Association. Guidelines for bronchial asthma prevention and treatment (2020 ed.) [J]. Chinese Journal of Tuberculosis and Respiratory Diseases,2020,43(12):1023-1048.
[17] 中华医学会变态反应分会呼吸过敏学组(筹),中华医学会呼吸病学分会哮喘学组.中国过敏性哮喘诊治指南(第1版,2019年)[J].中华内科杂志,2019,58(9):636-655.
Respiratory Allergy Group (in Preparation) of Chinese Society of Allergy of Chinese Medical Association, Asthma Group of Chinese Thoracic Society of Chinese Medical Association. Chinese guidelines for diagnosis and treatment of allergic asthma (2019, 1st ed.)[J]. Chinese Journal of Internal Medicine, 2019,58(9):636-655.
[18] 杨映映,王青,李青伟,等.诸疹痒喘嚏涕窍塞皆属于敏——仝小林教授对过敏性疾病的经验及病机探讨[J].吉林中医药,2018,38(6):633-637.
Yang YY, Wang Q, Li QW, et al. “Any syndromes including rash, itch, asthma, sneeze, running nose or congestion indicating allergic diseases” -- discussion about clinical experience and pathogenesis of allergic diseases by Professor Tong Xiaolin[J]. Jilin Journal of Chinese Medicine, 2018,38(6):633-637.
[19] 崔红生,姚海强,王济,等.国医大师王琦教授从体-病-证三维角度辨治过敏性哮喘经验[J].中华中医药杂志,2018,33(1):130-132.
Cui HS, Yao HQ, Wang J, et al. Clinical experience of TCM master Wang Qi in the treatment of allergic asthma based on three-dimensional differentiation of constitution-disease-syndrome[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2018,33(1):130-132.
[20] 武维屏,任传云.再谈肝与咳、喘、哮[J].中医杂志,2016,57(21):1886-1887.
Wu WP, Ren CY. Second discussion about the relationship between liver, cough and asthma[J]. Journal of Traditional Chinese Medicine, 2016,57(21):1886-1887.
[21] 杨玉萍,晁恩祥.国医大师晁恩祥教授从风论治呼吸疾病理论[J].中华中医药杂志,2014,29(12):3702-3704.
Yang YP, Chao EX. Study on the treatment of respiratory disease based on the theory of “treatment from wind” by Professor Chao En-xiang[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2014,29(12):3702-3704.
[22] 毕伟博.过敏性鼻炎-哮喘综合征证候学特点及苍耳桑梅方临床疗效评价[D].北京:北京中医药大学,2019.
Bi WB. Characteristics of syndrome on combined allergic rhinitis and asthma syndrome and clinical evaluations of Cangersangmei Decoction[D]. Beijing: Beijing University of Chinese Medicine, 2019.
[23] 陶敏,陈华,矫金玲.俞景茂运用养血疏风法治疗小儿过敏性疾病经验[J].中医杂志,2018,59(5):377-380.
Tao M, Chen H, Jiao JL. Yu Jingmao's experience in treating infantile allergic diseases by the method of nourishing blood and dispelling wind[J]. Journal of Traditional Chinese Medicine, 2018,59(5):377-380.
[24] 隋天姿,李竹英,刘建秋.刘建秋教授治疗过敏性鼻炎哮喘综合征经验[J].中国中医急症,2018,27(3):530-532.
Sui TZ, Li ZY, Liu JQ. Professor Liu Jianqiu's expe-rience on treating combined allergic rhinitis and asthma syndrome[J]. Journal of Emergency in Traditional Chinese Medicine, 2018,27(3):530-532.
[25] 崔红生,武维屏.从中医整体观谈变态反应性疾病从肺论治[J].中医杂志,2011,52(19):1702-1704.
Cui HS, Wu WP. Discussion on the treatment of allergic diseases from the lung under the guidance of the holistic view of traditional Chinese medicine[J]. Journal of Traditional Chinese Medicine, 2011,52(19):1702-1704.
[26] 崔红生,姚海强,王琦.基于辨体-辨病-辨证三维诊疗模式防治支气管哮喘[J].中医杂志,2015,56(22):1912-1914.
Cui HS, Yao HQ, Wang Q. Prevention and treatment of asthma by the pattern of Constitution-Disease-Syndrome Differentiation[J]. Journal of Traditional Chinese Medicine, 2015,56(22):1912-1914.
[27] 孙静,刘大新,季坤,等.固表化饮法治疗过敏性鼻炎哮喘综合征患者的临床疗效及对血清IgE和嗜酸性粒细胞的影响[J].世界中医药,2019,14(12):3260-3264.
Sun J, Liu DX, Ji K, et al. Clinical efficacy of consolidating superficies and resolving fluid method for patients with allergic rhinitis and asthma syndrome and its effects on serum total IgE eosinophils[J]. World Chinese Medicine, 2019,14(12):3260-3264.
[28] 邓玫.黄芪颗粒治疗过敏性鼻炎哮喘综合征患儿的疗效及对血清Th1、Th2细胞因子的影响[J].中医药学报,2017,45(2):68-71.
Deng M. Clinical effect of Huangqi granules on CARAS and its influence on serum Th1, Th2 cytokines[J]. Acta Chinese Medicine and Pharmacology, 2017,45(2):68-71.
[29] 邵素菊,张晓刚,王培育,等.邵氏“五针法”为主治疗过敏性鼻炎-哮喘综合征临床研究[J].中医学报,2017,32(2):185-189.
Shao SJ, Zhang XG, Wang PY, et al. Clinical research on Shao's Five Needling as the main method in treating for allergic rhinitis and asthma syndrome[J]. Acta Chinese Medicine, 2017, 32(2): 185-189.
[30] 臧焕焕,胡珀,王灵甫,等.基于IL-27探讨益气祛风、宣痹化饮方治疗过敏性鼻炎-哮喘综合征的作用机制[J].中成药,2018,40(2):447-452.
Zang HH, Hu P, Wang LF, et al. Discussion of the mechanism of Yiqi Qufeng Xuanbi Huayin Decoction in the treatment of CARAS based on IL-27 pathway[J]. Chinese Traditional Patent Medicine, 2018,40(2):447-452.
[31] 尹硕淼.基于TLR9/AP-1信号通路探讨益气袪风、宣痹化饮方治疗过敏性鼻炎-哮喘综合征的作用机制[D].南京:南京中医药大学,2016.
Yin SM. Clarify the mechanism about how to treat the di-sease of CARAS by Yiqi Qufeng Xuanbi Huayin Decoction on regulating the signal transduction pathway of TLR9/AP-1[D]. Nanjing: Nanjing University of Chinese Medicine, 2016.
[32] Yang SH, Yu CL, Yang YH, et al. The immune-modulatory effects of a mixed herbal formula on dendritic cells and CD4+ T lymphocytes in the treatment of dust mite a-llergy asthma and perennial allergic rhinitis[J]. J Asthma, 2016,53(4):446-451.
[33] Zhou K, Liu L, Shi S. Qu Feng Xuan Bi Formula attenuates anaphylactic rhinitis-asthma symptoms via reducing EOS count and regulating T cell function in rat ARA mo-dels[J]. J Ethnopharmacol, 2014,152(3):568-574.

中医药防治过敏性鼻炎-哮喘综合征研究述评^*

Evaluation of studies of prevention and treatment of combined allergic rhinitis and asthma syndrome with TCM^*

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

Metrics

本文评价

推荐阅读 0

[1]	刘爱民, 张步鑫, 赵巍, 徐胜东. 寻常型银屑病病因病机探讨^*[J]. 北京中医药大学学报, 2021, 44(3): 266-271.
[2]	贾春华. 中医病因病机理论的追问——以《伤寒论》太阳中风证及桂枝汤为案例^*[J]. 北京中医药大学学报, 2020, 43(7): 553-556.
[3]	王永炎, 邹忆怀, 谢颖桢. 再议中风先兆症的观察、病机与防治[J]. 北京中医药大学学报, 2020, 43(5): 423-426.
[4]	杨雪圆, 蔡宛灵, 闫小宁. 从中医“治未病”理论探讨黄褐斑的防治^*[J]. 北京中医药大学学报, 2020, 43(10): 870-875.
[5]	孙敬辉, 胡笑赢, 王承龙. 从肾气丸浅谈肾实证^*[J]. 北京中医药大学学报, 2017, 40(4): 281-283.
[6]	卢绪香, 贾新华, 朱雪, 邵雨萌, 张阳, 张伟. 从“肺毒”探析特发性肺纤维化^*[J]. 北京中医药大学学报, 2017, 40(4): 350-352.
[7]	秦国政. 精索静脉曲张性不育论治对策[J]. 北京中医药大学学报, 2016, 39(4): 341-343.
[8]	付春梅, 皮持衡, 傅建萍, 张玮玮, 杨文君. 论湿浊与慢性肾脏病[J]. 北京中医药大学学报, 2014, 37(10): 664-666.
[9]	胡建华李秀惠张秋云姚乃礼. 慢性乙型重型肝炎证候规律探讨[J]. 北京中医药大学学报, 2011, 34(03): 201-204.
[10]	蒋燕杨文思李鸫尤海燕. 荨麻疹的病名及病因病机探源[J]. 北京中医药大学学报, 2010, 33(09): 646-648.
[11]	张红梅陈雪功董昌武. 对汪昂"暑必兼湿"的再认识[J]. 北京中医药大学学报, 2010, 33(01): 11-12.

中医药防治过敏性鼻炎-哮喘综合征研究述评*

Evaluation of studies of prevention and treatment of combined allergic rhinitis and asthma syndrome with TCM*

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

Metrics

本文评价

推荐阅读 0

中医药防治过敏性鼻炎-哮喘综合征研究述评^*

Evaluation of studies of prevention and treatment of combined allergic rhinitis and asthma syndrome with TCM^*